(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

V VERITY PHARMACEUTICALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

V VERITY PHARMACEUTICALS

ST13

US500000087447270

Class

42

Filing

87447270

Registration

7341984

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

53

Latest update

10/30/2024

Trademark type

Combined

Nice classes

42

Filing date

05/12/2017

Registration date

04/02/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/02/2024

Last transaction

04/02/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

5

Owner type

03

Owner location

Mississauga, Ontario, CA

Examiner

WLODARCZYK, CAROLYN

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a stylized letter "V", with the stylized words "VERITY PHARMACEUTICALS" appearing in stacked formation to the right of the "V".

Holders and representatives

Holders

Verity Pharmaceuticals Inc.
Verity Pharmaceuticals Inc.

Representatives

NICOLE KINSLEY FOLEY HOAG LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Pharmaceutical company servicesprofessional medical company services being pharmaceutical product research and development

Publications

History of USPTO decisions and trademark events.

53 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/30/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/02/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/02/2024

TMBN

TTAB RELEASE CASE TO TRADEMARKS

02/27/2024

OP.T

OPPOSITION TERMINATED NO. 999999

02/27/2024

OP.D

OPPOSITION DISMISSED NO. 999999

02/27/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/11/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/11/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/11/2020

OP.I

OPPOSITION INSTITUTED NO. 999999

10/02/2020

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

08/10/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/14/2020

PUBO

PUBLISHED FOR OPPOSITION

07/14/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/24/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/04/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

06/04/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/04/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

06/04/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/04/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/26/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/26/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

05/26/2020

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

11/26/2019

GNSI

INQUIRY TO SUSPENSION E-MAILED

11/26/2019

CNSI

SUSPENSION INQUIRY WRITTEN

11/26/2019

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

11/06/2019

LOPR

LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN

10/11/2019

LOPT

LETTER OF PROTEST EVIDENCE FORWARDED

10/09/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

05/06/2019

GNSL

LETTER OF SUSPENSION E-MAILED

05/06/2019

CNSL

SUSPENSION LETTER WRITTEN

05/06/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/26/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/26/2019

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/23/2019

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

10/23/2018

GNSI

INQUIRY TO SUSPENSION E-MAILED

10/23/2018

CNSI

SUSPENSION INQUIRY WRITTEN

10/23/2018

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

10/01/2018

ALIE

ASSIGNED TO LIE

09/30/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/16/2018

GNSL

LETTER OF SUSPENSION E-MAILED

03/16/2018

CNSL

SUSPENSION LETTER WRITTEN

03/16/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/20/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/20/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/20/2018

LOPR

LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN

09/12/2017

LOPT

LETTER OF PROTEST EVIDENCE FORWARDED

09/11/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/21/2017

GNRT

NON-FINAL ACTION E-MAILED

08/21/2017

CNRT

NON-FINAL ACTION WRITTEN

08/21/2017

DOCK

ASSIGNED TO EXAMINER

08/10/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/17/2017

NWAP

NEW APPLICATION ENTERED

05/16/2017

Continuous trademark protection

Get notified about every new filing that threatens V VERITY PHARMACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.